SOHO Brazil 2024

 

SOHO Brazil 2024
J

How Are Targeted Therapies Redefining the Treatment Paradigm in ALL in Adults

By SOHO Brazil 2024 FEATURING Jan Burger
By SOHO Brazil 2024 FEATURING Jan Burger
128 views
July 11, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

09:50
Incyte

Managing Chronic GVHD Master Class Series: Best Practices at 100 Day…

Feat. C. Cutler

Featured Video

14:18
Incyte

Early Intervention in Chronic GVHD: Evaluating Efficacy and Safety O…

Feat. H. Ali
Videos
18:13

SOHO Brazil 2024: Treatment of Primary CNS Lymphoma

SOHO Brazil 2024

A. Alencar

117 views
20:49

Summary of Recent Updates in Advanced Hodgkin Lymphoma

SOHO Brazil 2024

C. Moskowitz

217 views
27:26

Where I Use Azacitidine and Venetoclax in AML: Present and Future

SOHO Brazil 2024

J. Lancet

534 views
22:29

1L Therapy in CLL: What Are the Best Options?

SOHO Brazil 2024

J. Burger

916 views
13:22

Managing Infectious Complications With Bispecific and CAR-T Therapy …

SOHO Brazil 2024

N. S. Raje

202 views
20:23

When to Consider Bispecific and CAR-T Therapy in MM

SOHO Brazil 2024

N. S. Raje

430 views
16:44

Frontline MM: Are Four Better Than Three?

SOHO Brazil 2024

N. S. Raje

84 views
19:14

FL: How Do I Deal With Relapse?

SOHO Brazil 2024

B. Kahl

509 views
15:25

To 2L and Beyond: Treatment Options in R/R MCL

SOHO Brazil 2024

T. Phillips

40 views
20:01

FL Updates: Is There a Standard 1L Treatment?

SOHO Brazil 2024

B. Kahl

331 views
21:12

3L in CLL: The Best Options in a Patient Double-Refractory to Covale…

SOHO Brazil 2024

J. Burger

561 views
18:29

Single vs. Multiple Agents in 2L Therapy for CLL

SOHO Brazil 2024

J. Burger

398 views
19:21

Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde

SOHO Brazil 2024

J. Lancet

598 views
17:01

Are We Closer to Conquering HR-MDS?

SOHO Brazil 2024

R. Komrokji

112 views
21:26

Therapies on the Horizon in LR- and HR-MDS

SOHO Brazil 2024

R. Komrokji

160 views
20:25

What Is the Best Timing for Bispecific Antibodies and CAR-T Therapy …

SOHO Brazil 2024

A. Zelenetz

63 views
14:17

DLBCL Pts Ineligible for CAR-T Therapy: Do They Exist and How Do We …

SOHO Brazil 2024

A. Zelenetz

127 views
15:02

Summary of Updates in R/R DLBCL Treatment

SOHO Brazil 2024

A. Alencar

110 views
22:11

Has the 1L SoC Truly Changed in Advanced Stage DLBCL?

SOHO Brazil 2024

A. Zelenetz

613 views
18:06

Summary of Recent Updates in R/R HL

SOHO Brazil 2024

C. Moskowitz

133 views
19:13

Summary of Recent Updates on LR-MDS Management

SOHO Brazil 2024

R. Komrokji

48 views
19:52

How Are Targeted Therapies Redefining the Treatment Paradigm in ALL …

SOHO Brazil 2024

J. Burger

128 views
19:07

Early Stage HL: Can Radiation Therapy Be Eliminated?

SOHO Brazil 2024

C. Moskowitz

115 views
38:54

PNH: Summary of Latest Advancements and Case Discussion

SOHO Brazil 2024

B. Fattizzo

252 views
20:33

The Gold Standard in the Use of FLT3 and IDH Inhibitors in AML

SOHO Brazil 2024

J. Lancet

142 views
17:30

Making Sense of 1L Treatment Options in MCL

SOHO Brazil 2024

T. Phillips

125 views